Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Passage Bio
Biotech
IGM, Y-mAbs, Passage Bio and more ring in 2025 with layoffs
IGM, Y-mAbs, Passage Bio and Shoreline Biosciences have each revealed plans to cut jobs as they rework their pipelines and business structures.
Fraiser Kansteiner
Jan 10, 2025 2:44pm
Passage looks to offload lead program, 2 other assets
Dec 20, 2023 1:29pm
Stanford president resigns—Chutes & Ladders
Jul 21, 2023 9:30am
Passage decides 26% staff, 2 execs not needed on clinical voyage
Jul 21, 2023 6:25am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
Layoff 'wave' not letting up amid oversaturation of biotechs
Mar 28, 2022 10:05am
